NM_014956.5:c.748G>A
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_014956.5(CEP164):c.748G>A(p.Gly250Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000372 in 1,613,538 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_014956.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000394 AC: 60AN: 152144Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000660 AC: 166AN: 251352Hom.: 1 AF XY: 0.000618 AC XY: 84AN XY: 135848
GnomAD4 exome AF: 0.000370 AC: 541AN: 1461394Hom.: 4 Cov.: 29 AF XY: 0.000384 AC XY: 279AN XY: 727052
GnomAD4 genome AF: 0.000394 AC: 60AN: 152144Hom.: 0 Cov.: 32 AF XY: 0.000377 AC XY: 28AN XY: 74322
ClinVar
Submissions by phenotype
CEP164-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Nephronophthisis 15 Benign:1
- -
not provided Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at